HIF1A and hepatocellular carcinoma: In addition, HK2 is the direct target of HIF‐1α in HCC cells.52 In this study, this is evidenced by the silencing of HK2 by siRNA enhancing the inhibitory effect of combination treatment on glycolysis and growth (Figure 5).